• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 outbreak and steroids administration: are patients treated for Sars-Cov-2 at risk of adrenal insufficiency?

作者信息

Scaroni C, Armigliato M, Cannavò S

机构信息

Endocrine Unit, Department of Medicine, Hospital-University of Padua, Padua, Italy.

Internal Medicine Unit, Mater Salutis Hospital, Legnago, VR, Italy.

出版信息

J Endocrinol Invest. 2020 Jul;43(7):1035-1036. doi: 10.1007/s40618-020-01253-1. Epub 2020 Apr 16.

DOI:10.1007/s40618-020-01253-1
PMID:32300975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7160238/
Abstract
摘要

相似文献

1
COVID-19 outbreak and steroids administration: are patients treated for Sars-Cov-2 at risk of adrenal insufficiency?2019冠状病毒病疫情与类固醇药物的使用：感染严重急性呼吸综合征冠状病毒2的患者是否有肾上腺功能不全的风险？
J Endocrinol Invest. 2020 Jul;43(7):1035-1036. doi: 10.1007/s40618-020-01253-1. Epub 2020 Apr 16.
2
Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection.糖皮质激素在肾上腺皮质功能不全合并新型冠状病毒肺炎感染患者中的应用。
Lancet Diabetes Endocrinol. 2020 Jun;8(6):472-473. doi: 10.1016/S2213-8587(20)30149-2. Epub 2020 Apr 23.
3
Adrenal insufficiency in coronavirus disease 2019: a case report.2019冠状病毒病中的肾上腺功能不全：一例报告
J Med Case Rep. 2020 Aug 24;14(1):134. doi: 10.1186/s13256-020-02461-2.
4
Antenatal corticosteroid therapy and COVID-19: Pathophysiological considerations.产前皮质类固醇治疗与2019冠状病毒病：病理生理学考量
Acta Obstet Gynecol Scand. 2020 Jul;99(7):952. doi: 10.1111/aogs.13887. Epub 2020 May 17.
5
Orthopaedic Considerations Following COVID-19: Lessons from the 2003 SARS Outbreak.2019冠状病毒病后的骨科考量：2003年严重急性呼吸综合征疫情的教训
JBJS Rev. 2020 Jul;8(7):e2000052. doi: 10.2106/JBJS.RVW.20.00052.
6
Pros and cons of corticosteroid therapy for COVID-19 patients.COVID-19 患者使用皮质类固醇治疗的利弊。
Respir Physiol Neurobiol. 2020 Sep;280:103492. doi: 10.1016/j.resp.2020.103492. Epub 2020 Jul 10.
7
COVID-19 coagulopathy: an evolving story.新冠病毒感染相关凝血功能障碍：一个不断演变的故事。
Lancet Haematol. 2020 Jun;7(6):e425. doi: 10.1016/S2352-3026(20)30151-4.
8
Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.使用多梳蛋白抑制剂作为抗病毒药物靶向严重急性呼吸综合征冠状病毒2（SARS-CoV-2）
Epigenomics. 2020 May;12(10):811-812. doi: 10.2217/epi-2020-0154. Epub 2020 Jun 4.
9
Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation.接受预防性抗凝治疗的新冠肺炎住院患者的静脉血栓栓塞症
Mayo Clin Proc. 2020 Oct;95(10):2291-2293. doi: 10.1016/j.mayocp.2020.08.014. Epub 2020 Aug 13.
10
The COVID-19 Pandemic and Mayo Clinic Proceedings.新冠疫情与《梅奥诊所学报》
Mayo Clin Proc. 2020 May;95(5):835-836. doi: 10.1016/j.mayocp.2020.04.009. Epub 2020 Apr 18.

引用本文的文献

1
Malignant hyperthermia in severe COVID-19: 2 case reports.重症新型冠状病毒肺炎中的恶性高热：2例病例报告
Emerg Crit Care Med. 2021 Sep 15;1(1):45-48. doi: 10.1097/EC9.0000000000000013. eCollection 2021 Sep.
2
Clinical characteristics of hospitalised patients with COVID-19 and the impact on mortality: a single-network, retrospective cohort study from Pennsylvania state.新冠肺炎住院患者的临床特征及其对死亡率的影响：宾夕法尼亚州的一项单网络回顾性队列研究
BMJ Open. 2021 Apr 8;11(4):e042549. doi: 10.1136/bmjopen-2020-042549. eCollection 2021.
3
COVID-19 pandemic and adrenals: deep insights and implications in patients with glucocorticoid disorders.COVID-19 大流行与肾上腺：糖皮质激素疾病患者的深入见解与影响
Endocrine. 2023 Oct;82(1):1-14. doi: 10.1007/s12020-023-03411-w. Epub 2023 Jun 20.
4
Hypothyroidism and Subclinical Hypothyroidism as a Consequence of COVID-19 Infection.甲状腺功能减退症和亚临床甲状腺功能减退症是 COVID-19 感染的后果。
Med Arch. 2022 Feb;76(1):12-16. doi: 10.5455/medarh.2022.76.12-16.
5
Association between Thyroid Disease and Severe Coronavirus Disease 2019 (COVID-19) Infection: A Meta-Analysis.甲状腺疾病与严重新型冠状病毒肺炎（COVID-19）感染之间的关联：一项荟萃分析。
Iran J Public Health. 2021 Aug;50(8):1517-1525. doi: 10.18502/ijph.v50i8.6797.
6
COVID-19 and the Endocrine System: A Comprehensive Review on the Theme.新型冠状病毒肺炎与内分泌系统：关于该主题的全面综述
J Clin Med. 2021 Jun 29;10(13):2920. doi: 10.3390/jcm10132920.
7
Perspectives on glucocorticoid treatment for COVID-19: a systematic review.关于 COVID-19 糖皮质激素治疗的观点：系统评价。
Pharmacol Rep. 2021 Jun;73(3):728-735. doi: 10.1007/s43440-021-00225-3. Epub 2021 Mar 5.
8
Endocrine Involvement in COVID-19: Mechanisms, Clinical Features, and Implications for Care.新型冠状病毒肺炎中的内分泌系统受累：机制、临床特征及对治疗的意义
Indian J Endocrinol Metab. 2020 Sep-Oct;24(5):381-386. doi: 10.4103/ijem.IJEM_440_20. Epub 2020 Nov 9.
9
What we have to know about corticosteroids use during Sars-Cov-2 infection.关于 SARS-CoV-2 感染期间使用皮质类固醇的问题，我们必须了解什么。
J Endocrinol Invest. 2021 Apr;44(4):693-701. doi: 10.1007/s40618-020-01384-5. Epub 2020 Aug 28.
10
Administration of Immunoglobulins in SARS-CoV-2-Positive Patient Is Associated With Fast Clinical and Radiological Healing: Case Report.SARS-CoV-2阳性患者使用免疫球蛋白与快速临床和影像学康复相关：病例报告
Front Med (Lausanne). 2020 Jul 16;7:388. doi: 10.3389/fmed.2020.00388. eCollection 2020.

本文引用的文献

1
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion.针对肾上腺功能不全的糖皮质激素替代治疗的调整：意大利内分泌学会专家意见。
J Endocrinol Invest. 2020 May;43(5):683-696. doi: 10.1007/s40618-019-01146-y. Epub 2019 Nov 26.
2
Dose Dependency of Iatrogenic Glucocorticoid Excess and Adrenal Insufficiency and Mortality: A Cohort Study in England.医源性糖皮质激素过量、肾上腺功能不全与死亡率的剂量依赖性：英国的一项队列研究
J Clin Endocrinol Metab. 2019 Sep 1;104(9):3757-3767. doi: 10.1210/jc.2019-00153.
3
Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone.利托那韦与氟替卡松联合治疗期间的医源性库欣综合征和肾上腺功能不全。
Springerplus. 2015 Aug 27;4:455. doi: 10.1186/s40064-015-1218-x. eCollection 2015.